Elizabeth Franklin

Elizabeth Franklin, PhD, MSW

Head, US Public Affairs and Patient Advocacy, Oncology Sanofi 

Elizabeth Franklin, PhD, MSW, is an advocate for people impacted by cancer and is passionate about ensuring that patient voices are the North Star in healthcare decision and policy making. Growing up in Kentucky, where cancer, cancer mortality, and poverty rates routinely rank among the highest in the country, Elizabeth was drawn to this work by witnessing people being left behind and systems that resulted in inequitable care. These values have driven her for almost two decades in oncology patient advocacy, public policy, research and executive positions in corporate and nonprofit settings.

Elizabeth currently serves as Head, U.S. Public Affairs and Patient Advocacy, Oncology with Sanofi, an innovative global healthcare company, where she partners with the U.S. advocacy community to advance innovation, ensure access, and improve health. Elizabeth previously held positions as President of the Cancer Support Community, Director of Policy and Engagement at the George Washington University Cancer Institute, Senior Director of Policy and Advocacy with the Prevent Cancer Foundation, and Special Assistant to the Chief Executive Officer at the headquarters of the National Association of Social Workers. 

Elizabeth is a recognized leader. She received the Association of Oncology Social Worker’s Quality of Life Award in 2022 and was named a 40 under 40 leader in oncology in 2020. Her research articles have appeared in publications such as the JCO Oncology Practice, Journal of Cancer Education, Journal of Clinical Pathways, Health and Social Work, Value in Health, and Conquer Cancer Magazine. She has co-authored 2 books on nonprofit leadership and co-edited 2 social work texts. In addition, she is a member and leader in various organizations and coalitions, including the Association of Oncology Social Work, Academy of Oncology Nurse and Patient Navigators, National Navigation Roundtable, and National Association of Social Workers.

Elizabeth earned her doctorate at the University of Maryland School of Social Work, where she focused her dissertation on the ways in which patients define value in the cancer care system and how those definitions can be incorporated into public policy and clinical practice. Elizabeth obtained her master's degree in social work from the University of Illinois at Chicago and her bachelor's degree in social work from the University of Kentucky. Elizabeth resides in Washington, D.C., and is an avid reader, aspiring banjo player, volunteer crisis counselor, and proud mother of pugs.

Blog Posts

blood samples in vials
Read December 15, 2020

Cancer Screening and Detection Innovation: What It Could Mean for Patients

Since the signing of the National Cancer Act in 1971, scientific and medical progress has resulted in extraordinary advancements in our ability to treat cancer. However, equally as important as treatment advances is our ability to detect cancer at the earliest stages, when the chance of surviving for at least 5 years is high.
Read June 25, 2020

What Cancer Patients, Survivors and Caregivers Need to Know about the Coronavirus

For many cancer patients and survivors with compromised immune systems, the reporting on this public health emergency may likely be source of anxiety. At a time when information is coming at us at a rapid pace, we are putting resources for you here, in one place. Read on to view a list of the resources we have and the actions CSC are taking to provide support to individuals affected by cancer.
Read December 14, 2018

Changes Proposed to Prescription Drug Commercials

In May of 2018, the Trump Administration committed to lowering the costs of prescription drugs and out-of-pocket spending for patients. One of the ways in which the Administration suggested meeting this goal was by changing the information available to consumers in television ads that market medications, which lead to a new rule that would require pharmaceutical companies to disclose the “list price” of drugs.